Fireside Chat: Building the Next Generation of CNS Pipelines Through Brain Delivery & Modality Innovation

• Determining which brain delivery technologies and therapeutic modalities warrant integration into long-term neuroscience portfolios
• Establishing evidence thresholds for advancing CNS delivery platforms from discovery-stage innovation into clinical development
• Balancing investments across internal R&D, platform partnerships, licensing opportunities, and external innovation ecosystems
• Identifying the biological, translational, and regulatory advances most likely to unlock the next wave of CNS therapeutic development

Speakers:

Sophie Parmentier-Batteur

Head of Neurodegeneration

Novartis